Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer

ÇAĞLAR TUNCALI M., Bozkurt F. M., KAPULU AKÇA C. D., Vargol S. E., BAYRAKTAR M., UĞUR Ö., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.33, sa.3, ss.268-274, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1097/mnm.0b013e32834ec5d6
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.268-274
  • Anahtar Kelimeler: iodine-131, radioiodine ablation, thyroid cancer, LOW-DOSE RADIOIODINE, WHOLE-BODY SCAN, SERUM THYROGLOBULIN, RADIOACTIVE IODINE, FOLLOW-UP, THERAPY, CARCINOMA, PAPILLARY, ULTRASONOGRAPHY, MANAGEMENT
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction The initial treatment of differentiated thyroid cancer is thyroidectomy, followed by remnant ablation with iodine-131 (I-131) in some patients. However, controversy exists concerning the appropriate radioiodine dose. The aim of the study is to compare the success rate of low and high activities of I-131 for postoperative remnant ablation.